LYEL
Price
$20.81
Change
-$1.29 (-5.84%)
Updated
Dec 2 closing price
Capitalization
468.92M
Intraday BUY SELL Signals
TSHA
Price
$4.06
Change
-$0.37 (-8.35%)
Updated
Dec 2 closing price
Capitalization
1.21B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LYEL vs TSHA

Header iconLYEL vs TSHA Comparison
Open Charts LYEL vs TSHABanner chart's image
Lyell Immunopharma
Price$20.81
Change-$1.29 (-5.84%)
Volume$40.84K
Capitalization468.92M
Taysha Gene Therapies
Price$4.06
Change-$0.37 (-8.35%)
Volume$3.31M
Capitalization1.21B
LYEL vs TSHA Comparison Chart in %
LYEL
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LYEL vs. TSHA commentary
Dec 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a StrongBuy and TSHA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 03, 2025
Stock price -- (LYEL: $20.81 vs. TSHA: $4.06)
Brand notoriety: LYEL and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 113% vs. TSHA: 47%
Market capitalization -- LYEL: $468.92M vs. TSHA: $1.21B
LYEL [@Biotechnology] is valued at $468.92M. TSHA’s [@Biotechnology] market capitalization is $1.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whileTSHA’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • TSHA’s FA Score: 0 green, 5 red.
According to our system of comparison, TSHA is a better buy in the long-term than LYEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 3 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).

  • LYEL’s TA Score: 3 bullish, 4 bearish.
  • TSHA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TSHA is a better buy in the short-term than LYEL.

Price Growth

LYEL (@Biotechnology) experienced а -7.63% price change this week, while TSHA (@Biotechnology) price change was -11.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.91%. For the same industry, the average monthly price growth was -4.84%, and the average quarterly price growth was +52.68%.

Reported Earning Dates

TSHA is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-1.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.21B) has a higher market cap than LYEL($469M). TSHA YTD gains are higher at: 134.682 vs. LYEL (62.578). TSHA has higher annual earnings (EBITDA): -91.48M vs. LYEL (-199.95M). TSHA has more cash in the bank: 313M vs. LYEL (277M). LYEL has less debt than TSHA: LYEL (46.6M) vs TSHA (59.6M). TSHA has higher revenues than LYEL: TSHA (8.1M) vs LYEL (60K).
LYELTSHALYEL / TSHA
Capitalization469M1.21B39%
EBITDA-199.95M-91.48M219%
Gain YTD62.578134.68246%
P/E RatioN/A2.70-
Revenue60K8.1M1%
Total Cash277M313M88%
Total Debt46.6M59.6M78%
TECHNICAL ANALYSIS
Technical Analysis
LYELTSHA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LYEL
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLUEX13.610.09
+0.67%
Lazard US Equity Concentrated R6
BDOIX12.340.05
+0.41%
iShares MSCI Total Intl Idx Instl
MEMGX43.080.15
+0.35%
MFS Emerging Markets Equity R3
PGILX41.540.05
+0.12%
Putnam Focused Equity Y
NBNAX15.17N/A
N/A
Neuberger Berman International Sel A

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-5.84%
VCYT - LYEL
46%
Loosely correlated
-0.50%
CRBU - LYEL
36%
Loosely correlated
-0.56%
RLYB - LYEL
36%
Loosely correlated
+0.31%
BEAM - LYEL
36%
Loosely correlated
-2.83%
RXRX - LYEL
36%
Loosely correlated
-0.92%
More

TSHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with PCVX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
-8.35%
PCVX - TSHA
51%
Loosely correlated
-1.80%
NGNE - TSHA
50%
Loosely correlated
-6.05%
RGNX - TSHA
49%
Loosely correlated
-3.10%
SLDB - TSHA
44%
Loosely correlated
-2.11%
BEAM - TSHA
43%
Loosely correlated
-2.83%
More